Table 1 Clinical and pathological characteristics of TCGA and GEO data sets
Characteristics | TCGA (n = 495) | GSE116918 (n = 248) |
|---|---|---|
Age, n (%) | ||
≤ 60 | 222(44.8) | 35(14.1) |
> 60 | 273(55.2) | 213(85.9) |
PSA, n (%) | ||
≤ 10 | – | 50(20.2) |
> 10 | – | 198(79.8) |
T stage, n (%) | ||
T1 | – | 51(20.6) |
T2 | 187(37.8) | 76(30.6) |
T3 | 291(58.8) | 92(37.1) |
T4 | 10(2.0) | 4(1.6) |
NA | 7(1.4) | 25(10.1) |
N stage, n (%) | ||
N0 | 344(69.5) | – |
N1 | 78(15.8) | – |
NA | 73(14.7) | – |
Gleason score, n (%) | ||
< 7 | 45(9.1) | 42(17.0) |
= 7 | 246(49.7) | 99(39.9) |
> 7 | 204(41.2) | 107(43.1) |
MET, n (%) | ||
No | 444(89.7) | 226(91.1) |
Yes | 17(3.4) | 22(8.9) |
NA | 34(6.9) | – |